Shashank Gorityala

Shashank Gorityala

Covance Laboratories - Princeton / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4819572
-
person_outline Shashank Gorityala's MOST POPULAR ARTICLES
1-) 5-Fluorouracil Enhances the Antitumor Activity of the Glutaminase Inhibitor CB-839 against PIK3CA-Mutant Colorectal CancersY Zhao, X Feng, Y Chen, JE Selfridge, S Gorityala, Z Du, JM Wang, Y Hao, ...Cancer research 80 (21), 4815-4827, 2020742020
2-) Recent trends in design and evaluation of chitosan-based colon targeted drug delivery systems: Update 2020M Kurakula, S Gorityala, K MoharirJournal of Drug Delivery Science and Technology 64, 102579, 2021692021
3-) RNF126 as a biomarker of a poor prognosis in invasive breast cancer and CHEK1 inhibitor efficacy in breast cancer cellsX Yang, Y Pan, Z Qiu, Z Du, Y Zhang, P Fa, S Gorityala, S Ma, S Li, ...Clinical Cancer Research 24 (7), 1629-1643, 2018432018
4-) Inhibition of uracil DNA glycosylase sensitizes cancer cells to 5-fluorodeoxyuridine through replication fork collapse-induced DNA damageY Yan, X Han, Y Qing, AG Condie, S Gorityala, S Yang, Y Xu, Y Zhang, ...Oncotarget 7 (37), 59299, 2016362016
5-) Targeting radioresistant breast cancer cells by single agent CHK1 inhibitor via enhancing replication stressY Zhang, J Lai, Z Du, J Gao, S Yang, S Gorityala, X Xiong, O Deng, Z Ma, ...Oncotarget 7 (23), 34688, 2016342016